NCT05805605
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
Clinical trial condition
Prolymphocytic Leukemia
Explore clinical trials studying Prolymphocytic Leukemia. Study availability and eligibility vary by location and protocol.
44 public trials
4 recruiting studies
Prolymphocytic Leukemia trial results
Recruiting
Observatory of Prolymphocytic Leukemia T
NCT04411043
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Chd Le Mans Le Mans, France
NCT03314974
- Conditions
- Acquired Bone Marrow Failure Syndromes, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT04195633
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +59 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, not recruiting
Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
NCT02007044
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia
NCT02029443
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
- Locations
-
- Research Site Boston, Massachusetts, United States
- Research Site New Hyde Park, New York, United States
- Research Site New York, United States
- Research Site Columbus, Ohio, United States
Active, not recruiting
PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
NCT01589302
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Active, not recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
NCT02296918
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
- Locations
-
- Research Site Columbus, Ohio, United States